Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters










Publication year range
1.
Health Phys ; 99(3): 413-9, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20699706

ABSTRACT

Self-assembled monolayer on mesoporous supports (SAMMS) are hybrid materials created from attachment of organic moieties onto very high surface area mesoporous silica. SAMMS with surface chemistries including three isomers of hydroxypyridinone, diphosphonic acid, acetamide phosphonic acid, glycinyl urea, and diethylenetriamine pentaacetate (DTPA) analog were evaluated for chelation of actinides ((239)Pu, (241)Am, uranium, thorium) from blood. Direct blood decorporation using sorbents does not have the toxicity or renal challenges associated with traditional chelation therapy and may have potential applications for critical exposure cases, reduction of nonspecific dose during actinide radiotherapy, and for sorbent hemoperfusion in renal insufficient patients, whose kidneys clear radionuclides at a very slow rate. Sorption affinity (K(d)), sorption rate, selectivity, and stability of SAMMS were measured in batch contact experiments. An isomer of hydroxypyridinone (3,4-HOPO) on SAMMS demonstrated the highest affinity for all four actinides from blood and plasma and greatly outperformed the DTPA analog on SAMMS and commercial resins. In batch contact, a fifty percent reduction of actinides in blood was achieved within minutes, and there was no evidence of protein fouling or material leaching in blood after 24 h. The engineered form of SAMMS (bead format) was further evaluated in a 100-fold scaled-down hemoperfusion device and showed no blood clotting after 2 h. A 0.2 g quantity of SAMMS could reduce 50 wt.% of 100 ppb uranium in 50 mL of plasma in 18 min and that of 500 dpm mL(-1) in 24 min. 3,4-HOPO-SAMMS has a long shelf-life in air and at room temperature for at least 8 y, indicating its feasibility for stockpiling in preparedness for an emergency. The excellent efficacy and stability of SAMMS materials in complex biological matrices suggest that SAMMS can also be used as orally administered drugs and for wound decontamination. By changing the organic groups of SAMMS, they can be used not only for actinides but also for other radionuclides. By using the mixture of these SAMMS materials, broad spectrum decorporation of radionuclides is very feasible.


Subject(s)
Actinoid Series Elements/blood , Actinoid Series Elements/isolation & purification , Chelating Agents/chemistry , Decontamination/methods , Actinoid Series Elements/chemistry , Adsorption , Americium/blood , Americium/isolation & purification , Humans , Isomerism , Pentetic Acid/chemistry , Plutonium/blood , Plutonium/isolation & purification , Porosity , Pyridones/chemistry , Radiation Injuries/prevention & control , Radioactive Hazard Release , Terrorism , Thorium/blood , Thorium/isolation & purification , Time Factors , Uranium/blood , Uranium/isolation & purification
2.
Hum Exp Toxicol ; 12(3): 233-9, 1993 May.
Article in English | MEDLINE | ID: mdl-8100434

ABSTRACT

This study has examined the efficacy of ZnDTPA administered in drinking water for removing 238Pu and 241Am from the rat after their simultaneous inhalation as nitrates; the dosage used was 95 mumol kg-1d-1. The continuous administration of ZnDTPA over a 14 d interval, commencing 1 h after exposure, reduced the lung and total body contents of 238Pu to, respectively, 11% and 18% of those in untreated rats; the corresponding values for 241Am were 11% and 14%. After the continuous administration of 95 mumol kg-1 from 4 d to 28 d post exposure, the lung and total body contents of 238Pu were, respectively, 5% and 16% of those in controls; the corresponding values for 241Am were 7% and 19%. Further reductions in the actinide contents of body tissues were found when treatment was extended to 52 d or 76 d. These regimens were as effective as twice weekly injections of 30 mumol kg-1 ZnDTPA commencing at 4 d. After the continuous administration of 95 mumol kg-1 d-1 for 72 d, some pathological changes to the gastrointestinal tract were observed but these were considered to be reparable. It was concluded that further work is required to evaluate the toxicity of the ligand and to establish the optimal treatment regimen.


Subject(s)
Americium/pharmacokinetics , Chelating Agents/pharmacology , Pentetic Acid/pharmacology , Plutonium/pharmacokinetics , Administration, Inhalation , Administration, Oral , Americium/administration & dosage , Americium/blood , Animals , Chelating Agents/administration & dosage , Drinking , Female , Injections, Intraperitoneal , Lung/drug effects , Lung/metabolism , Metabolic Clearance Rate/drug effects , Pentetic Acid/administration & dosage , Pentetic Acid/toxicity , Plutonium/administration & dosage , Plutonium/blood , Rats , Rats, Inbred Strains
3.
Health Phys ; 63(6): 641-50, 1992 Dec.
Article in English | MEDLINE | ID: mdl-1428884

ABSTRACT

The biokinetics of 239Pu and 241Am present in three dust samples obtained from Maralinga were investigated after their deposition in the rat lung. Results were used as an experimental basis for assessing the radiological implications for human exposure. The transfer rates of these actinides to blood in the various dusts differed by 50-fold. The most transportable forms were compatible with a material that had 25% class W and 75% class Y characteristics. The doses per unit intake for adults, children, and infants exposed to an aerosol of 5 microns AMAD were calculated to be, respectively, 0.059, 0.076, and 0.140 mSv Bq-1. The corresponding doses for the least transportable forms were the same as those calculated for a class Y compound, namely 0.036, 0.049, and 0.096 mSv Bq-1. The behavior of the actinides in humans was predicted by combining the transfer rates to blood with mechanical clearance data obtained after volunteers had inhaled 85Sr or 88Y labeled fused aluminosilicate particles. The results suggested that monitoring of 241Am in the chest could be used to advantage for assessing intakes incurred by workers involved with any further decontamination procedures but would be of little practical value for assessing inadvertent public exposure. The paper includes comments on the relevance of the 1990 ICRP recommendations and the proposed new dosimetric model for the respiratory tract.


Subject(s)
Americium/pharmacokinetics , Dust , Lung/metabolism , Nuclear Warfare , Plutonium/pharmacokinetics , Radioactive Fallout , Administration, Inhalation , Americium/administration & dosage , Americium/blood , Animals , Female , Plutonium/administration & dosage , Plutonium/blood , Rats , South Australia
4.
Hum Toxicol ; 5(3): 163-73, 1986 May.
Article in English | MEDLINE | ID: mdl-3710493

ABSTRACT

To examine the kinetic behaviour of americium, plutonium and uranium in the different organs of male and female rats an extended mammillary model has been developed; the model is composed of 10 compartments connected with 17 linear transfer coefficients. The 10 compartments describe the behaviour of the three nuclides in the blood, skeleton, liver and kidney, whereas the remaining activity is assigned to one residual organ. Each organ is divided into two compartments, a short- and long-term compartment. Morphologically, in the skeleton the short-term compartment has been assumed to be the bone surface and bone marrow and the long-term compartment to be the deep bone, whereas in the liver there is some evidence to suggest that the short-term compartment is physiologically associated with lysosomes and the long-term compartment is identical with telolysosomes. The influence of age, sex and different nuclides on the transfer coefficients and the absorbed radiation dose have been discussed. Additionally, by using the transfer coefficients calculated for intravenous injection, the behaviour of the nuclides in skeleton and liver during continuous intake has been calculated. As a second example of the application of the model the behaviour of the three nuclides in skeleton and liver after intravenous injection has been calculated with the additional assumption that from the fifth day on the animals were treated continuously with a chelating agent.


Subject(s)
Americium/metabolism , Plutonium/metabolism , Uranium/metabolism , Americium/blood , Animals , Bone and Bones/metabolism , Female , Kidney/metabolism , Kinetics , Liver/metabolism , Male , Models, Biological , Plutonium/blood , Rats , Rats, Inbred Strains , Uranium/blood
14.
Nature ; 210(5042): 1283-4, 1966 Jun 18.
Article in English | MEDLINE | ID: mdl-5967816
SELECTION OF CITATIONS
SEARCH DETAIL
...